企業(yè)檔案
- 會(huì)員類型:免費(fèi)會(huì)員
- 工商認(rèn)證: 【已認(rèn)證】
- 最后認(rèn)證時(shí)間:
- 法人:
- 注冊(cè)號(hào):
- 企業(yè)類型:生產(chǎn)商
- 注冊(cè)資金:人民幣萬(wàn)
聯(lián)系我們
聯(lián)系人:楊燕燕
熱門標(biāo)簽
技術(shù)文章
人表皮生長(zhǎng)因子,不含動(dòng)物成分
點(diǎn)擊次數(shù):24 發(fā)布時(shí)間:2024/8/8 16:51:23
生物來(lái)源
human
質(zhì)量水平
重組
expressed in E. coli
檢測(cè)方案
>97% (SDS-PAGE)
形式
lyophilized powder
效能
0.08-0.8 ng/mL EC50
分子量
~6 kDa
包裝
pkg of 200 and 500 μg
儲(chǔ)存條件
avoid repeated freeze/thaw cycles
雜質(zhì)
≤1 EU/μg Endotoxin

一般描述
表皮生長(zhǎng)因子(EGF)在Henle′s環(huán)和腎遠(yuǎn)曲小管中合成。它也在唾液腺和十二指腸中產(chǎn)生。[1]
表皮生長(zhǎng)因子(EGF)是小的促有絲分裂多肽(∼6 6 kDa),存在于許多哺乳動(dòng)物物種中,分布在許多組織和體液中。†人EGF與β-尿抑胃素相同,β-尿抑胃素是基于其胃酸分泌抑制能力而被識(shí)別和分離的多肽。† EGF是生長(zhǎng)因子家族的成員,其特征在于存在6個(gè)保守的半胱氨酸基序,形成了三個(gè)二硫鍵。重組人EGF中3個(gè)鏈內(nèi)二硫鍵的位置與小鼠EGF的位置相同。†EGF與牛痘病毒19 kDa蛋白中包含的序列同源,† 該病毒可能利用EGF受體進(jìn)入細(xì)胞[2]† EGF對(duì)多種表皮和上皮細(xì)胞具有促有絲分裂作用,包括成纖維細(xì)胞、神經(jīng)膠質(zhì)細(xì)胞、乳腺上皮細(xì)胞、血管和角膜內(nèi)皮細(xì)胞、牛粒層細(xì)胞、兔軟骨細(xì)胞、HeLa細(xì)胞和SV40-3T3細(xì)胞。†
應(yīng)用
生化/生理作用
表皮生長(zhǎng)因子(EGF)有助于誘導(dǎo)細(xì)胞生長(zhǎng)、增殖和分化。它可參與腎臟中腎組織的修復(fù)。它可借助瞬時(shí)受體電位陽(yáng)離子通道6(TRMP6)促進(jìn)鎂的重吸收。EGF已被發(fā)現(xiàn)可參與藥物性腎鎂丟失的病理生理過(guò)程。[1]
引用
1. Carpenter, G., and Cohen, S., Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. Annu. Rev. Biochem., 48, 193-216 (1979).
2.Gregory, H., Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature, 257, 325-327 (1975).
3.George-Nascimento, C. et al., Characterization of recombinant human epidermal growth factor produced in yeast. Biochemistry, 27, 797-802 (1988).
4.Todaro, G.J. et al., Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA, 77, 5258-5262 (1980).
5.Blomquist, M.C. et al., Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors. Proc. Natl. Acad. Sci. USA, 81, 7363-7367 (1984).
6.Eppstein, D.A. et al., Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. Nature, 318, 663-665 (1985).
2.Gregory, H., Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature, 257, 325-327 (1975).
3.George-Nascimento, C. et al., Characterization of recombinant human epidermal growth factor produced in yeast. Biochemistry, 27, 797-802 (1988).
4.Todaro, G.J. et al., Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA, 77, 5258-5262 (1980).
5.Blomquist, M.C. et al., Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors. Proc. Natl. Acad. Sci. USA, 81, 7363-7367 (1984).
6.Eppstein, D.A. et al., Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. Nature, 318, 663-665 (1985).
原創(chuàng)作者:上海篤瑪生物科技有限公司